Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
<p>Abstract</p> <p>Background</p> <p>Afghanistan's national guidelines recommend chloroquine for the treatment of <it>Plasmodium vivax </it>infection, the parasite responsible for the majority of its malaria burden. Chloroquine resistance in <it>P...
Main Authors: | Woodrow Charles J, Dondorp Arjen M, Imwong Mallika, Pukrittayakamee Sasithon, Awab Ghulam, Lee Sue, Day Nicholas PJ, Singhasivanon Pratap, White Nicholas J, Kaker Faizullah |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-04-01
|
Series: | Malaria Journal |
Online Access: | http://www.malariajournal.com/content/9/1/105 |
Similar Items
-
Therapeutic and Transmission-Blocking
Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia
by: Jean Popovici, et al.
Published: (2018-08-01) -
Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017
by: Kasama Rakmark, et al.
Published: (2020-07-01) -
Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.
by: Jeanne Rini Poespoprodjo, et al.
Published: (2014-01-01) -
A population survey of the glucose-6-phosphate dehydrogenase (G6PD) 563C>T (Mediterranean) mutation in Afghanistan.
by: Natsuda Jamornthanyawat, et al.
Published: (2014-01-01) -
Artemisinin-napthoquine versus dihydroartemisinin-piperaquine in adult subjects with Plasmodium vivax infection
by: Armedy Ronny Hasugian, et al.
Published: (2016-03-01)